Prestwick3_000493

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

106 Suppliers, 42 USDMF, 36 CEP/COS, 10 JDMF, 26 EU WC, 26 KDMF, 35 NDC API, 64 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

23 Suppliers

23 Suppliers

DOSSIERs // Finished Dosage Forms

836 Dossiers, 94 FDA Orange Book, 503 Europe, 11 Canada, 53 Australia, 38 South Africa, 137 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE, DELAYED REL PELLETS;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 325MG;40MG, TABLET, DELAYED RELEASE;ORAL - 81MG;40MG, TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL - 20MG, CAPSULE;ORAL - 20MG;1.1GM, CAPSULE;ORAL - 40MG;1.1GM, TABLET, DELAYED RELEASE;ORAL - 20MG, CAPSULE;ORAL - 20MG;1.1GM, CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 40 BASF, 38 Kerry, 23 Roquette, 20 SPI Pharma, 19 Microlex e.U, 15 Corel Pharma Chem, 14 Seppic, 14 Ideal Cures Pvt Ltd, 13 Gangwal Healthcare, 13 Gangwal Chemicals, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 Sigachi Industries, 9 Nanjing Well Pharmaceutical, 9 Boai NKY Pharmaceuticals Ltd, 9 Actylis, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 DFE Pharma, 6 Lonza Capsugel, 5 Ingredion Pharma Solutions, 5 Prachin Chemical, 5 Pharmatrans-Sanaq, 5 Rochem International Inc, 4 Vasa Pharmachem, 4 ACG Worldwide, 4 Kima Chemical, 4 Ulanqab Kema New Material, 4 Finar, 3 Doshion Polyscience, 3 Jai Radhe Sales, 3 Alcedo Pharmachem, 3 DKSH, 3 The Dow Chemical Company, 2 Pfanstiehl, 2 Nanjing Bold Chemical, 2 Pharm-RX Chemical, 2 Qualicaps, 2 Nomisma Healthcare, 2 Seqens, 2 Vertellus, 2 Evonik, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Zhejiang Huakang Pharmaceutical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Minakem, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Aeon Procare, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Bioplus Life Sciences

EXCIPIENTS BY APPLICATIONS

94 Fillers, Diluents & Binders, 76 Coating Systems & Additives, 48 Direct Compression, 48 Controlled & Modified Release, 45 Disintegrants & Superdisintegrants, 37 Solubilizers, 35 Granulation, 34 Thickeners and Stabilizers, 30 Taste Masking, 28 Lubricants & Glidants, 23 Topical, 22 Film Formers & Plasticizers, 22 Chewable & Orodispersible Aids, 20 Parenteral, 18 Co-Processed Excipients, 9 Empty Capsules, 8 API Stability Enhancers, 8 Emulsifying Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 453 Finished Drug Prices

MARKET PLACE

56 APIs, 71 DOSSIERS // FDF, 1 EXCIPIENTS

PATENTS

11 US Patents, 23 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 BioAnalytical Methods, 1 Analytical Solutions, 3 EDQM Standards, 5 USP Standards, 50 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 78 News

Latest U.S. Prescription Data for Drugs containing Prestwick3_000493 under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services Website

Prestwick3_000493

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

106 Suppliers

42 USDMF

36 CEP/COS

10 JDMF

26 EU WC

26 KDMF

35 NDC API

64 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

23 Suppliers

DOSSIERs // Finished Dosage Forms

836 Dossiers

94 FDA Orange Book

503 Europe

11 Canada

53 Australia

38 South Africa

137 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE, DELAYED REL PELLETS;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED REL PELLETS;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - 325MG;40MG

TABLET, DELAYED RELEASE;ORAL - 81MG;40MG

TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL - 20MG

CAPSULE;ORAL - 20MG;1.1GM

CAPSULE;ORAL - 40MG;1.1GM

TABLET, DELAYED RELEASE;ORAL - 20MG

CAPSULE;ORAL - 20MG;1.1GM

CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

40 BASF

38 Kerry

23 Roquette

20 SPI Pharma

19 Microlex e.U

15 Corel Pharma Chem

14 Seppic

14 Ideal Cures Pvt Ltd

13 Gangwal Healthcare

13 Gangwal Chemicals

12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

12 Sigachi Industries

9 Nanjing Well Pharmaceutical

9 Boai NKY Pharmaceuticals Ltd

9 Actylis

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 DFE Pharma

6 Lonza Capsugel

5 Ingredion Pharma Solutions

5 Prachin Chemical

5 Pharmatrans-Sanaq

5 Rochem International Inc

4 Vasa Pharmachem

4 ACG Worldwide

4 Kima Chemical

4 Ulanqab Kema New Material

4 Finar

3 Doshion Polyscience

3 Jai Radhe Sales

3 Alcedo Pharmachem

3 DKSH

3 The Dow Chemical Company

2 Pfanstiehl

2 Nanjing Bold Chemical

2 Pharm-RX Chemical

CAPSULE, DELAYED REL PELLETS;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, DELAYED REL PELLETS;ORAL - 40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons